Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients
This study is currently recruiting participants.
Verified August 2012 by Columbia University
Sponsor:
Columbia University
Collaborators:
Bayer
Onyx Pharmaceuticals
Information provided by (Responsible Party):
Abby Siegel, Columbia University
ClinicalTrials.gov Identifier:
NCT00997022
First received: October 14, 2009
Last updated: August 24, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2016 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |